Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing all 3 results
v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
v4i3: pp. 27-42 James E Meyer; Patrick Fitzgerald; Mostafa Moini; Business Valuation and Lost Profits 1994
v2i1: pp. 1-16 Jerome S Osteryoung; Kirk Brown; Mark Henniger; Business Valuation and Lost Profits 1992
Subtotal: $25.00